These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24576472)

  • 21. Immunity to poliomyelitis in Victorians.
    Hogg K; Hogg G; Lester R; Uren E
    Aust N Z J Public Health; 2002 Oct; 26(5):432-6. PubMed ID: 12413287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population immunity to polioviruses in the context of a large-scale wild poliovirus type 1 outbreak in Tajikistan, 2010.
    Khetsuriani N; Pallansch MA; Jabirov S; Saparova N; Oberste MS; Wannemuehler K; Ursu P; Wassilak S; Martin R
    Vaccine; 2013 Oct; 31(42):4911-6. PubMed ID: 23891502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in Poliovirus Seroprevalence in Kano State, Northern Nigeria.
    Verma H; Iliyasu Z; Craig KT; Molodecky NA; Urua U; Jibir BW; Gwarzo GD; Gajida AU; McDonald S; Weldon WC; Oberste MS; Braka F; Mkanda P; Sutter RW
    Clin Infect Dis; 2018 Oct; 67(suppl_1):S103-S109. PubMed ID: 30376090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neutralizing antibodies against poliovirus serotypes among children in southwest Nigeria.
    Adewumi MO; Donbraye E; Odaibo GN; Bakarey AS; Opaleye OO; Olaleye DO
    J Trop Pediatr; 2006 Apr; 52(2):92-5. PubMed ID: 16014758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunity levels to poliovirus in Lao children and adults before the vaccine-derived poliovirus outbreak: A retrospective study.
    Pauly M; Black AP; Khampanisong P; Nouanthong P; Hübschen JM; Nanthavong N; Sayasinh K; Jutavijittum P; Samountry B; Xeuatvongsa A; Diedrich S; Muller CP
    PLoS One; 2018; 13(5):e0197370. PubMed ID: 29763458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
    Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
    Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poliovirus immunity among children under five years-old in accessible areas of Afghanistan, 2013.
    Hsu CH; Wannemuehler KA; Soofi S; Mashal M; Hussain I; Bhutta ZA; McDuffie L; Weldon W; Farag NH
    Vaccine; 2019 Mar; 37(12):1577-1583. PubMed ID: 30782488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing population immunity in a persistently high-risk area for wild poliovirus transmission in India: a serological study in Moradabad, Western Uttar Pradesh.
    Deshpande JM; Bahl S; Sarkar BK; Estívariz CF; Sharma S; Wolff C; Sethi R; Pathyarch SK; Jain V; Gary HE; Pallansch MA; Jafari H
    J Infect Dis; 2014 Nov; 210 Suppl 1(Suppl 1):S225-33. PubMed ID: 25316839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A comparison of the effectiveness of mass immunization campaign of trivalent oral poliovirus vaccine (TOPV) by epidemiological serosurvey. Shandong Collaborating Group for Poliomyelitis Control and Surveillance, Jinan, Shandong].
    Xu A
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Oct; 13(5):261-4. PubMed ID: 1338626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-Term Protection against Diphtheria in the Netherlands after 50 Years of Vaccination: Results from a Seroepidemiological Study.
    Swart EM; van Gageldonk PG; de Melker HE; van der Klis FR; Berbers GA; Mollema L
    PLoS One; 2016; 11(2):e0148605. PubMed ID: 26863307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A national cross-sectional study for poliovirus seroprevalence in the Republic of Korea in 2012: implication for deficiency in immunity to polio among middle-aged people.
    Kim HJ; Hwang S; Lee S; Kwon Y; Park K; Park YJ; Bae GR; Lee SW; Jeong YS; Hyeon JY
    BMC Infect Dis; 2015 Mar; 15():164. PubMed ID: 25881203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Status of immunity against poliomyelitis. Polio serosurvey in 1993].
    Diedrich S; Schreier E
    Dtsch Med Wochenschr; 1995 Feb; 120(8):239-44. PubMed ID: 7867480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
    O'Ryan M; Bandyopadhyay AS; Villena R; Espinoza M; Novoa J; Weldon WC; Oberste MS; Self S; Borate BR; Asturias EJ; Clemens R; Orenstein W; Jimeno J; Rüttimann R; Costa Clemens SA;
    Lancet Infect Dis; 2015 Nov; 15(11):1273-82. PubMed ID: 26318714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The maintaining of the active laboratory-based surveillance of the acute flaccid paralysis (AFP) cases in Romania in the framework of the strategic plan of the global polio eradication initiative.
    Băicuş A; Persu A; Combiescu M; Aubert-Combiescu A
    Roum Arch Microbiol Immunol; 2007; 66(1-2):44-50. PubMed ID: 18928063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Status of immunity against poliomyelitis: a study among European and extra-European young immigrants living in Parma.
    Affanni P; Veronesi L; Rizziero S; Bizzoco S; Bracchi MT; Tanzi ML
    Acta Biomed; 2005 Dec; 76(3):157-63. PubMed ID: 16676565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Analysis of neutralized antibody level of the poliomyelitis in healthy population in Fujian province].
    He AH; Wang H; Yang XH; Xu JY; Zhang HR; Huang LF
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Oct; 24(5):352-4. PubMed ID: 21280322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The German Health Interview and Examination Survey for Children and Adolescents (KiGGS): state of immunity against poliomyelitis in German children].
    Diedrich S; Schreier E
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007; 50(5-6):771-4. PubMed ID: 17514462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of anti-poliovirus type 1, 2 and 3 antibodies in unvaccinated Italian travelers.
    Signorini L; Barbi M; Matteelli A; Binda S; Didò P; Caroppo S; Primache V; Pisani S; Messino C; Brunelli M; Costa P; Ronca E; Fausti C; Castelli F
    J Travel Med; 2004; 11(1):34-6. PubMed ID: 14769285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seroprevalence of poliovirus antibodies among children in a Dominican community--Puerto Rico, 2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Jun; 54(23):580-1. PubMed ID: 15959453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6-9 months in Moradabad, India: a community-based, randomised controlled trial.
    Estívariz CF; Jafari H; Sutter RW; John TJ; Jain V; Agarwal A; Verma H; Pallansch MA; Singh AP; Guirguis S; Awale J; Burton A; Bahl S; Chatterjee A; Aylward RB
    Lancet Infect Dis; 2012 Feb; 12(2):128-35. PubMed ID: 22071249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.